However, the significant reductions in CTGF and TGFB1 mRNA observed with LY3214996 treatment were not reflected in protein levels for those factors where protein levels trended lower but were not significantly different due to inter-donor SAE BC variation (Fig. 4b). Here, CCN2 is linked to breast cancer.